Julong vs Lichen International
JLHL and LICN side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How JLHL and LICN compare
Julong keeps more of each dollar of sales as profit, with a net margin of 4523% compared with −2715% at Lichen International.
Julong scores higher on the StockData Score (6 against 5 for Lichen International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | JLHL | LICN |
|---|---|---|
| Size and price | ||
| Share price | $4.79 | $0.030 |
| Change, 1 year | 18.9% | −99.1% |
| Beta (5Y) | 1.74 | 0.81 |
| Employees | 46 | 399 |
| StockData Score | ||
| Total score | 6 (better) | 5 |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 3 (better) | 0 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −97.4% | – |
| Revenue growth, 5Y average | – | −51.7% |
| Net income growth (TTM) | −32.3% | – |
| EPS growth (TTM) | −31.8% | – |
| Profitability | ||
| Gross margin | 15846% (better) | 1129% |
| Operating margin | 12070% (better) | −2234% |
| Net margin | 4523% (better) | −2715% |
| FCF margin | – | −2206% |
| Return on equity | 21.2% (better) | −35.1% |
| Return on invested capital | 81.1% (better) | −34.4% |
| Financial health | ||
| Debt / equity | 0.12 (better) | 0.00 |
| Net debt / EBITDA | −1.08 | – |
| Current ratio | 1.21 | 5.81 (better) |
| Piotroski F-score | 6 (better) | 3 |
| Ownership | ||
| Held by insiders | 93.2% | 0.00% |
| Short interest, % of float | – | 0.62% |
Go deeper
- JLHL stock overview
- JLHL income statement
- JLHL valuation and score
- LICN stock overview
- LICN income statement
- LICN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.